Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

The First Aspartic Acid of the DQxD Motif for Human UDP-Glucuronosyltransferase 1A10 Interacts with UDP-Glucuronic Acid during Catalysis

Yan Xiong, Anne-Sisko Patana, Michael J. Miley, Agnieszka K. Zielinska, Stacie M. Bratton, Grover P. Miller, Adrian Goldman, Moshe Finel, Matt R. Redinbo and Anna Radominska-Pandya
Drug Metabolism and Disposition March 2008, 36 (3) 517-522; DOI: https://doi.org/10.1124/dmd.107.016469
Yan Xiong
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anne-Sisko Patana
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael J. Miley
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Agnieszka K. Zielinska
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stacie M. Bratton
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Grover P. Miller
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adrian Goldman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Moshe Finel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matt R. Redinbo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna Radominska-Pandya
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 36 no. 3 517-522
DOI 
https://doi.org/10.1124/dmd.107.016469
PubMed 
18048489

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received May 1, 2007
  • Accepted November 26, 2007
  • Published online February 22, 2008.

Article Versions

  • Earlier version (November 29, 2007 - 07:35).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Yan Xiong,
  2. Anne-Sisko Patana,
  3. Michael J. Miley,
  4. Agnieszka K. Zielinska,
  5. Stacie M. Bratton,
  6. Grover P. Miller,
  7. Adrian Goldman,
  8. Moshe Finel,
  9. Matt R. Redinbo and
  10. Anna Radominska-Pandya
  1. Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, Arkansas (Y.X., A.K.Z., S.M.B., G.P.M., A.R.-P.); Structural Biology and Biophysics, Institute of Biotechnology (A.-S.P., A.G.), and Neuroscience Center (A.G.), University of Helsinki, Helsinki, Finland; Departments of Chemistry (M.J.M.) and Biochemistry and Biophysics (M.R.R.), Program in Molecular Biology and Biotechnology (M.R.R.), and the Lineberger Comprehensive Cancer Center (M.R.R.), University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; and Drug Discovery and Development Technology Center, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland (M.F.)
  1. Address correspondence to:
    Dr. Anna Radominska-Pandya, University of Arkansas for Medical Sciences, 4301 W. Markham, Slot 516, Little Rock, AR 72205. E-mail: radominskaanna{at}uams.edu
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2017 to March 2023

AbstractFullPdf
Aug 20170157
Sep 2017198
Oct 20171153
Nov 20170187
Dec 20170121
Jan 2018092
Feb 20180107
Mar 20181244
Apr 20182211
May 20180265
Jun 20180185
Jul 20180110
Aug 20180100
Sep 20180113
Oct 20180120
Nov 20180184
Dec 2018245
Jan 2019501
Feb 2019401
Mar 20191500
Apr 20191701
May 20191202
Jun 2019804
Jul 2019911
Aug 20191102
Oct 2019611
Nov 20192500
Dec 20192314
Jan 20201001
Feb 2020701
Mar 20201101
May 2020601
Jun 2020600
Jul 20201300
Aug 2020302
Sep 20201010
Oct 20201301
Nov 2020602
Dec 2020501
Jan 20211134
Feb 20211013
Mar 20211122
Apr 2021820
May 20213340
Jun 20211021
Jul 2021913
Aug 2021922
Sep 20211121
Oct 2021210
Nov 2021914
Dec 20211523
Jan 20221111
Feb 2022611
Mar 20222022
Apr 20221421
May 2022360
Jun 20221210
Jul 202214110
Aug 20221721
Sep 20221011
Oct 2022821
Nov 20221416
Dec 20221422
Jan 20231820
Feb 2023613
Mar 2023710

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 36 (3)
Drug Metabolism and Disposition
Vol. 36, Issue 3
1 Mar 2008
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
The First Aspartic Acid of the DQxD Motif for Human UDP-Glucuronosyltransferase 1A10 Interacts with UDP-Glucuronic Acid during Catalysis
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

The First Aspartic Acid of the DQxD Motif for Human UDP-Glucuronosyltransferase 1A10 Interacts with UDP-Glucuronic Acid during Catalysis

Yan Xiong, Anne-Sisko Patana, Michael J. Miley, Agnieszka K. Zielinska, Stacie M. Bratton, Grover P. Miller, Adrian Goldman, Moshe Finel, Matt R. Redinbo and Anna Radominska-Pandya
Drug Metabolism and Disposition March 1, 2008, 36 (3) 517-522; DOI: https://doi.org/10.1124/dmd.107.016469

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

The First Aspartic Acid of the DQxD Motif for Human UDP-Glucuronosyltransferase 1A10 Interacts with UDP-Glucuronic Acid during Catalysis

Yan Xiong, Anne-Sisko Patana, Michael J. Miley, Agnieszka K. Zielinska, Stacie M. Bratton, Grover P. Miller, Adrian Goldman, Moshe Finel, Matt R. Redinbo and Anna Radominska-Pandya
Drug Metabolism and Disposition March 1, 2008, 36 (3) 517-522; DOI: https://doi.org/10.1124/dmd.107.016469
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • A PBPK model for CBD in adults and children
  • rs2242480 Regulates the Expression of CYP3A4 and CYP3A5
  • Absorption, Metabolism, and Excretion of Taselisib
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics